McSweeney Mary E, Garwood Susan, Levin Jack, Marino Maria R, Wang Shirley X, Kardatzke David, Mangano Dennis T, Wolman Richard L
*Multicenter Study of Perioperative Ischemia Research Group and University of Wisconsin Medical School, Madison, Wisconsin; †Yale University School of Medicine, New Haven, Connecticut; ‡School of Medicine and VA Medical Center, San Francisco, California; §Centro Cardiologico Monzino, Milano, Italy; and ‖The Ischemia Research and Education Foundation, San Francisco, California.
Anesth Analg. 2004 Jun;98(6):1610-1617. doi: 10.1213/01.ANE.0000113556.40345.2E.
Adverse gastrointestinal (GI) outcome after cardiac surgery is an infrequent event but is a clinically important health care problem because of associated increased morbidity and mortality. The ability to identify patients at greatest risk before surgery may be helpful in planning appropriate perioperative management strategies. We examined the pre- and intraoperative characteristics of 2417 patients from 24 diverse United States medical centers enrolled in the Multicenter Study of Perioperative Ischemia Study who were undergoing cardiac surgery using cardiopulmonary bypass as predictors for adverse GI outcome. Resource utilization was evaluated for patients with and without adverse GI outcomes. Adverse GI outcomes occurred in 5.5% of patients (133 of 2417), increased in-hospital mortality 6.5-fold, prolonged the mean intensive care unit length of stay by 1 wk, and more than doubled the mean postoperative hospital stay (P < 0.0001). Predictors of adverse GI outcome included decreased left ventricular function, hyperbilirubinemia, thrombocytopenia, prolonged partial thromboplastin time, prior cardiovascular surgery, combined coronary artery bypass graft surgery and intracardiac or proximal aortic surgery, pharmacological cardiovascular support, and intraoperative transfusion. The literature suggests that adverse GI outcome after cardiac surgery is secondary to poor splanchnic perfusion, which many of these risk factors may predict. Therefore, patients deemed to be at risk before surgery may benefit from tightly controlled hemodynamic management and other strategies that optimize perioperative organ perfusion.
We identified the preoperative and intraoperative predictors associated with an increased incidence of postoperative gastrointestinal complications after cardiac surgery using cardiopulmonary bypass. Because these complications are associated with frequent morbidity and mortality, these predictors may be helpful in identifying patients at increased risk so that risk stratification can be modified and perioperative management can be appropriately adjusted.
心脏手术后不良胃肠道(GI)结局是一种不常见的事件,但由于其相关的发病率和死亡率增加,是一个临床上重要的医疗保健问题。在手术前识别出风险最高的患者,对于制定适当的围手术期管理策略可能会有所帮助。我们研究了来自美国24个不同医疗中心的2417例患者的术前及术中特征,这些患者参加了围手术期缺血性疾病多中心研究,正在接受使用体外循环的心脏手术,以此作为不良GI结局的预测指标。对有和没有不良GI结局的患者的资源利用情况进行了评估。5.5%的患者(2417例中的133例)出现了不良GI结局,住院死亡率增加了6.5倍,重症监护病房平均住院时间延长了1周,术后平均住院时间增加了一倍多(P<0.0001)。不良GI结局的预测指标包括左心室功能下降、高胆红素血症、血小板减少、部分凝血活酶时间延长、既往心血管手术史、冠状动脉搭桥术与心内或近端主动脉手术联合进行、药物性心血管支持以及术中输血。文献表明,心脏手术后不良GI结局继发于内脏灌注不良,而这些危险因素中的许多可能可以预测这一点。因此,术前被认为有风险的患者可能会从严格控制的血流动力学管理和其他优化围手术期器官灌注的策略中获益。
我们确定了使用体外循环的心脏手术后与术后胃肠道并发症发生率增加相关的术前和术中预测指标。由于这些并发症与频繁发生的发病率和死亡率相关,这些预测指标可能有助于识别风险增加的患者,以便可以修改风险分层并适当调整围手术期管理。